Source: Eur Respir Rev, 29 (158) 190140; 10.1183/16000617.0140-2019
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Antoine Froidure, Emmeline Marchal-Duval, Meline Homps-Legrand, Mada Ghanem, Aurélien Justet, Bruno Crestani, Arnaud Mailleux. Chaotic activation of developmental signalling pathways drives idiopathic pulmonary fibrosis. Eur Respir Rev, 29 (158) 190140; 10.1183/16000617.0140-2019

Member's Comments

No comment yet.

Related content which might interest you: PP208 – SRC family kinases modulate molecular pathways associated with mitochondrial dysfunction in idiopathic pulmonary fibrosis Source: ERS Lung Science Conference 2021 Year: 2021 Involvement of the Hedgehog signalling pathway in idiopathic pulmonary fibrosis Source: Annual Congress 2011 - Growth factors and fibrogenesis: are they good, bad or both? Year: 2011 Dysregulation of the TGF-beta system in idiopathic pulmonary fibrosis Source: Eur Respir J 2004; 24: Suppl. 48, 10s Year: 2004 mTOR signalling is an essential pathway for TGF-β1 induced collagen synthesis Source: International Congress 2015 – Pulmonary fibrosis: mechanisms of disease Year: 2015 Defective p53-mediated pro-apoptotic pathway in idiopathic pulmonary fibrosis Source: Annual Congress 2008 - New insights into the pathogenesis of idiopathic pulmonary fibrosis and sarcoidosis Year: 2008 Reactivation of developmental pathways in idiopathic pulmonary fibrosis: FGF9 and FGF18 modulate the phenotype of control and fibrotic human lung fibroblasts in vitro Source: International Congress 2015 – IPF: from bench to bedside Year: 2015 Increased pulmonary Wnt signaling in patients with sarcoidosis Source: Annual Congress 2007 - Interstitial lung disease: diagnostic and therapeutic novelties Year: 2007 The matrix-fibroblast interplay contributes to HIF-1 alpha pathway activation: a possible therapeutic target in idiopathic pulmonary fibrosis (IPF) Source: Virtual Congress 2020 – Elucidating the mechanisms underlying lung repair and exploring therapeutic strategies in vitro Year: 2020 TRIM33 prevents pulmonary fibrosis by impairing TGF-ß1 signalling Source: Eur Respir J, 55 (6) 1901346; 10.1183/13993003.01346-2019 Year: 2020 Wnt signalling and parenchymal fibrosis Source: Lung Science Conference 2009 - Cell proliferation, Differentiation and Carcinogenesis Year: 2009 Non-canonical WNT signaling is mediated by extracellular vesicles in pulmonary fibrosis Source: ERS Lung Science Conference 2016 Year: 2016 Four-and-a-half-LIM-domain (FHL)-2 acts as an enhancer of TGF-beta signaling in pulmonary fibrosis Source: Eur Respir J 2007; 30: Suppl. 51, 296s Year: 2007 LSC - 2021 - SRC family kinases modulate molecular pathways associated with mitochondrial dysfunction in idiopathic pulmonary fibrosis Source: Virtual Congress 2021 – Cellular and molecular involvement in lung injury and repair Year: 2021 Mast cells and fibroblasts work in concert to aggravate pulmonary fibrosis: Role of transmembrane SCF and PAR-2/PKCalpha/Raf-1/p44/42 signaling pathway Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis and rarities Year: 2013 6-aminonicotinamide ameliorates pulmonary fibrosis by suppressing the TGF-beta1 activated Smad signalling pathway Source: Virtual Congress 2020 – Translational therapeutic advances Year: 2020 LSC Abstract – Non-canonical WNT signaling is mediated by extracellular vesicles in pulmonary fibrosis Source: International Congress 2016 – New genomic targets in pulmonary disease Year: 2016 Mitochondrial antiviral signaling protein is crucial for the development of pulmonary fibrosis Source: Eur Respir J, 57 (4) 2000652; 10.1183/13993003.00652-2020 Year: 2021 Targeting the mTOR signaling pathway to inhibit lung cell senescence in chronic obstructive pulmonary disease (COPD) Source: ERS Lung Science Conference 2017 Year: 2017 Age-driven developmental drift in the pathogenesis of idiopathic pulmonary fibrosis Source: Eur Respir J 2016; 48: 538-552 Year: 2016